UN says U.S. HIV funding cuts may lead to 4M deaths, 6M new infections by 2029 if support isn’t replaced. Global health programs face a crisis.
Decades of Progress at Risk
The United Nations has issued a stark warning that recent cuts to U.S. funding for global HIV/AIDS programs could lead to over 4 million deaths and 6 million new infections by 2029. A report released Thursday by UNAIDS highlights that the sudden funding withdrawal has destabilized life-saving programs that have, for decades, helped control the epidemic in some of the world’s most vulnerable regions.
Sudden Withdrawal Causes Global Disruption
Over the past six months, the sharp reduction in American financial support—especially through the President’s Emergency Plan for AIDS Relief (PEPFAR)—has caused what UNAIDS describes as a “systemic shock.” Clinics have closed, supply chains are disrupted, and testing, treatment, and prevention efforts have been curtailed across sub-Saharan Africa and other high-risk areas. PEPFAR, established in 2003, was once the largest single-disease health initiative in history.
Critical Health Systems Collapsing
UNAIDS reports that thousands of community organizations and health facilities are now operating without adequate staff or medicine. The crisis is compounded by fears that other major donors could follow the U.S. lead and scale back their commitments amid geopolitical tensions and shifting international priorities.
Andrew Hill, a University of Liverpool researcher, criticized the lack of notice, saying that responsible governments typically offer transition timelines. “Instead, clinics were shut overnight, leaving patients stranded,” he said.
A Lifeline Severed
PEPFAR was instrumental in treating over 20 million people and testing more than 84 million worldwide. In Nigeria, the program supported nearly 100% of the national budget for preventive HIV medication. UNAIDS considers the initiative a “lifeline” and warns that losing it now will erase decades of hard-fought gains against AIDS.
Global figures from 2024 estimate 630,000 AIDS-related deaths, a number that had plateaued since 2022. Progress has always been uneven, with half of all new infections still occurring in sub-Saharan Africa.
Limited Options for Affected Countries
Health experts emphasize that low-income nations are not in a position to compensate for the abrupt loss of U.S. funding. “There’s nothing we can do that will protect these countries from the sudden, vicious withdrawal,” said Tom Ellman of Doctors Without Borders in South Africa.
Beyond medical care, the U.S. also funded crucial surveillance systems, including hospital and patient records. Without these, public health experts warn, it will become nearly impossible to track and respond to new outbreaks.
Breakthrough Treatment Faces Access Barriers
Adding to the concern, a new injectable HIV prevention drug—Yeztugo—was recently approved by the U.S. FDA and shown to be 100% effective in trials. However, pricing issues and limited generic licensing threaten to keep it out of reach for most who need it.
While South Africa’s government has pledged to prioritize adolescent access to the drug, global health advocates argue that without restored funding and affordable pricing, the opportunity to end the AIDS epidemic may slip away.
“We could be ending AIDS,” said Peter Maybarduk of Public Citizen. “Instead, the U.S. is abandoning the fight.”
For continuous coverage and real-time updates, keep following Maple News Wire.
